The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

28 days Prescribing information 70% insulin aspart protamine suspension and 30% insulin as part injection (rDNA origin) pen fill cartridge Novolog Mix 70/30 pen fill cartridge (Novo Nordisk ...

Pharmapack wrapped up last week with two full days of new product innovation, networking, and informative talks, sessions, ...

NICE tuned down the GLP-1 agonist earlier this year, but changed its stance after Novo Nordisk offered a confidential discount to the NHS. Saxenda – which comes as prefilled self-injection pen ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Diabetes specialist Novo Nordisk is feeling the heat from increasingly ... innovation in insulin products and user-friendly insulin pen devices. The company also expanded into haemophilia and ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...